The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.

The DARWIN EU links national databases to deliver real-world evidence that supports safer and faster regulatory decisions.

Gabapentin is approved for seizures and postherpetic neuralgia; gabapentin enacarbil is approved for restless legs syndrome.

Import duties are posing a challenge to some smaller companies, which fear that raising prices to cover higher costs will ...

President Donald Trump announced Monday that the US Food and Drug Administration will be notifying physicians that the use of ...

Mindstate Design Labs, backed by Silicon Valley power players, has created what its CEO calls “the least psychedelic ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary ... s classroom file with their medication. At school, ensure your child’s inhaler is clearly labeled. Put a ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

Scientists say that Trump distorted facts on vaccines, Tylenol and autism during a news conference in which he encouraged ...

As a pharmacy benefits optimization (PBO), RxBenefits has a 30-year legacy in delivering pharmacy benefits options that ...

ClearPoint Neuro surged over 100% following positive Huntington’s Disease data from partner uniQure. Click here to find out ...

The White House's autism announcement exaggerates links to Tylenol, misleads on vaccines, and sets back the field by ignoring ...